Table 3.
Factors | VAP (n = 82) | Non-VAP (n = 115) | P | |
---|---|---|---|---|
BI | 52.47 ± 15.29 | 71.29 ± 19.26 | 16.26 | 0.001 |
Rebleeding rate | 27 (32.9%) | 18 (15.6%) | 8.71 | 0.002 |
Mortality rate | 21 (25.6%) | 12 (10.4%) | 6.76 | 0.01 |
Factors | VAP (n = 82) | Non-VAP (n = 115) | P | |
---|---|---|---|---|
BI | 52.47 ± 15.29 | 71.29 ± 19.26 | 16.26 | 0.001 |
Rebleeding rate | 27 (32.9%) | 18 (15.6%) | 8.71 | 0.002 |
Mortality rate | 21 (25.6%) | 12 (10.4%) | 6.76 | 0.01 |